As a result of our commitment to research and innovation, BrudyTechnology has obtained up to the date one European patent and two world patents, granted for the treatment of tumour diseases, dyslipidaemia and cellular oxidative damage.


Patente tumorales


Patent WO 2006120120 A1: Use of docosahexaenoic glycerides for the treatment of tumorous diseases


Patente HIV


Patent WO 2004050077 A1: Use of docosahexanoic acid as active substance for the treatment of lipodystrophy


Patente oxidación


Patent WO 2007/071733 A3: Use of dha, epa or dha-derived epa for treating a pathology associated with cellular oxidative damage